MPCi is a Beijing-based venture capital firm investing in China-focused early- and later-stage companies, with emphasis on new technology, hard tech, industrial digitalization, healthcare, frontier technology and new consumer sectors. The firm backs biotechnology, life sciences, oncology, pharmaceuticals, HealthTech, medical devices and TMT companies, and has acted as a lead or co-lead investor in healthcare and oncology financings.